Literature DB >> 31336308

Optimization of a single HPLC-PDA method for quantifying Metformin, Gliclazide, Pioglitazone, Dapagliflozin, Empagliflozin, Saxagliptin, Linagliptin and Teneligliptin using central composite design.

Ravi Kant1, Ramesh Babu Bodla2, Garima Kapoor2, Rubina Bhutani2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31336308     DOI： 10.1016/j.bioorg.2019.103111

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN： 0045-2068            Impact factor:   5.275


× No keyword cloud information.
  2 in total

1.  Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Metformin Hydrochloride in Tablet Dosage Forms by HPLC.

Authors:  Mousa Sha'at; Adrian Florin Spac; Iulian Stoleriu; Alexandra Bujor; Monica Stamate Cretan; Mihaela Hartan; Lacramioara Ochiuz
Journal:  Pharmaceutics       Date:  2022-05-31       Impact factor: 6.525

2.  Economic Spectrofluorometric Bioanalysis of Empagliflozin in Rats' Plasma.

Authors:  Bassam Ayoub; Noha El Zahar; Haidy Michel; Mariam Tadros
Journal:  J Anal Methods Chem       Date:  2021-05-11       Impact factor: 2.193
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.